Cargando…
2481. Impact of Sex and Race/Ethnicity on the Effectiveness of Live Zoster Vaccine
BACKGROUND: Zostavax™, a live zoster vaccine licensed as 1 dose, is indicated in the United States for the prevention of herpes zoster (HZ) in people 50 years or older. Real-world vaccine effectiveness (VE) and duration of protection are being evaluated in an ongoing study. Compared with randomized...
Autores principales: | Marks, Morgan A, Bartlett, Joan, Fireman, Bruce, Hansen, John, Lewis, Ned, Aukes, Laurie, Saddier, Patricia, Klein, Nicola P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255362/ http://dx.doi.org/10.1093/ofid/ofy210.2134 |
Ejemplares similares
-
Effectiveness of Live Zoster Vaccine in Preventing Herpes Zoster Ophthalmicus (HZO)
por: Aukes, Laurie, et al.
Publicado: (2017) -
1047 Use of electronic data to identify new zoster cases for a vaccine effectiveness study
por: Baxter, Roger, et al.
Publicado: (2014) -
Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records
por: Klein, Nicola P, et al.
Publicado: (2023) -
Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study
por: Baxter, Roger, et al.
Publicado: (2018) -
22. An Innovative Approach to Examining the Waning of Vaccine Effectiveness Using Automated Healthcare Data
por: Aukes, Laurie, et al.
Publicado: (2021)